Lord, Abbett & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$127M Sell
242,726
-2,070
-0.8% -$989K 0.41% 62
2025
Q4
$143M Buy
244,796
+142,653
+140% +$72.9M 0.44% 61
2025
Q3
$46.8M Buy
102,143
+17,926
+21% +$6.69M 0.14% 174
2025
Q2
$25.5M Sell
84,217
-33,807
-29% -$10.1M 0.08% 247
2025
Q1
$39.1M Buy
118,024
+69,107
+141% +$22.7M 0.14% 180
2024
Q4
$15.1M Buy
+48,917
New +$13.8M 0.05% 355
2024
Q2
Sell
-97,103
Closed -$25.9M 567
2024
Q1
$25.9M Buy
+97,103
New +$22.9M 0.08% 289
2023
Q3
Sell
-67,918
Closed -$15.7M 560
2023
Q2
$15.7M Sell
67,918
-107
-0.2% -$29K 0.05% 382
2023
Q1
$16.5M Sell
68,025
-110,493
-62% -$30.1M 0.06% 379
2022
Q4
$51.8M Buy
+178,518
New +$17.5M 0.19% 158
2018
Q3
Sell
-92,193
Closed -$25.8M 864
2018
Q2
$25.8M Buy
92,193
+31,993
+53% +$5.62M 0.08% 409
2018
Q1
$7.03M Sell
60,200
-42,042
-41% -$5.19M 0.02% 671
2017
Q4
$9.38M Buy
+102,242
New +$5.84M 0.03% 633

Other funds holding MDGL